Welcome to our dedicated page for Organigram Holdings Common Shares news (Ticker: OGI), a resource for investors and traders seeking the latest updates and insights on Organigram Holdings Common Shares stock.
OrganiGram Holdings Inc. (symbol: OGI) is a leading licensed producer of cannabis, based in Atlantic Canada. As part of Canada’s Marihuana for Medical Purposes Regulations (MMPR), OrganiGram specializes in the cultivation of high-quality, organically grown medical marijuana. The company is committed to providing the best possible medicine and service to its clients.
OrganiGram’s primary operations revolve around the production of indoor-grown cannabis for both medical patients and adult recreational users in Canada. The company has built a diverse portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Recently, Organigram has expanded its brand lineup with the addition of Tremblant Cannabis and the artisanal craft brand, Laurentian.
OrganiGram has garnered recognition for its innovative and high-quality cannabis products. The company places a strong emphasis on research and development to continually improve its cultivation techniques and product offerings. OrganiGram has also established significant partnerships which support its growth and expansion plans.
Financially, OrganiGram has shown resilience and adaptability in a competitive market. The company regularly updates investors and stakeholders with the latest developments and financial results, ensuring transparency and fostering trust.
OrganiGram Holdings Inc. is dedicated to advancing the cannabis industry through sustainable practices and a commitment to quality. For more information or inquiries, visit www.organigram.ca or contact their client services team at 1-855-961-9420.
Organigram Holdings reported a robust Q1 Fiscal 2023, achieving a 43% increase in net revenue to $43.3 million, up from $30.4 million in the previous year. The company also recorded an Adjusted EBITDA of $5.6 million, marking its fourth consecutive quarter of positive earnings. The Adjusted Gross Margin reached a historic 30%, rising from 18% in the same period last year, driven by operational efficiencies and increased sales volume. Organigram maintained its competitive position in the Canadian market and shipped $5.9 million of product internationally.
Organigram Holdings Inc. (NASDAQ: OGI) will report its earnings results for Q1 fiscal 2023, ending November 30, 2022, on January 12, 2023, before market open. A conference call will be held at 8:00 AM Eastern Time on the same day to discuss the results. Participants can register for the call online and will receive access details via email. Organigram is a leading cannabis producer in Canada, focused on high-quality products and expanding its global footprint through various brands and international partnerships.
Flow Beverage Corp. (OTCQX: FLWBF; TSX: FLOW) has appointed Stephen A. Smith and Michael Lines to its Board of Directors. Smith, with a strong background in finance, will chair the Audit Committee, while Lines, founder of Wellness Natural Inc., will chair the Governance, Human Resources & Compensation Committee. Their appointments aim to enhance Flow's strategic transformation and focus on profitable growth in the consumer packaged goods sector. Flow is recognized as one of North America's fastest-growing premium water companies, emphasizing sustainable practices and health-oriented products.
Organigram Holdings reported a record net revenue of $45.5 million for Q4 Fiscal 2022, an 83% increase year-over-year, and $145.8 million for the fiscal year, up 84%. Adjusted EBITDA stood at $3.2 million for Q4, marking the third consecutive quarter of positive EBITDA, compared to a loss of $4.8 million in the prior year. The company achieved significant market share gains, holding the #1 position in Ontario and the Maritimes. With expanded capacity and operational efficiencies, Organigram is poised for continued growth in Fiscal 2023.
Organigram Holdings Inc. (NASDAQ: OGI) has announced the launch of its new value brand, HOLY MOUNTAIN, focused on affordable whole flower and concentrates. The initial offerings include dried flower strains like R*NTZ and MAC-1, alongside a pressed hash product. This expansion aims to enhance accessibility for consumers across Canada. Organigram is a leading cannabis producer, with plans to continue innovating and responding to consumer demands.
Organigram Holdings Inc. (NASDAQ: OGI) will report its earnings results for the fiscal year and fourth quarter ended August 31, 2022 on November 28, 2022, after market close. The company will conduct a conference call on November 29, 2022, at 8:00 am ET, to discuss these results. Interested participants can register for the call through a provided link. Organigram is a leading cannabis producer in Canada, focused on high-quality cannabis products for patients and recreational consumers.
Organigram is set to supply InterCure with up to 20,000 kg of dried cannabis flower over several years, following a successful 3,000 kg supply agreement fulfilled since June 2020. This new multi-year agreement includes an initial commitment of 10,000 kg with an option for an additional 10,000 kg within three years. Approximately 2,800 kg has already been delivered. The collaboration aims to support both companies’ international expansion strategies, contingent upon compliance with local regulations.
Organigram achieved a record net revenue of $38.1 million in Q3 Fiscal 2022, marking an 88% increase from the previous year. Gross revenue also saw a 90% rise to $55.2 million. The company maintained a 7.8% market share among Canadian licensed producers and remained the top player in dried flower products. New SKUs were introduced, including SHRED-X vapes and CBN Bedtime Blueberry Lemon gummies. However, net loss decreased to $2.8 million, and cash reserves fell by 31% year-over-year.
Organigram Holdings Inc. (NASDAQ: OGI) announced it will report its earnings results for Q3 2022, ending May 31, 2022, on July 14, 2022, before the market opens. A conference call is scheduled for the same day at 8:00 am Eastern Time to discuss the results. Interested participants can register through provided links and access the live call or a replay later. Organigram, a licensed producer of cannabis and cannabis-derived products in Canada, focuses on high-quality products for patients and adult recreational consumers.
FAQ
What is the current stock price of Organigram Holdings Common Shares (OGI)?
What is the market cap of Organigram Holdings Common Shares (OGI)?
What is OrganiGram Holdings Inc.?
What types of cannabis products does OrganiGram offer?
Where is OrganiGram Holdings Inc. based?
How can I contact OrganiGram's client services team?
Is OrganiGram involved in research and development?
What regulations does OrganiGram operate under?
Is OrganiGram Holdings Inc. publicly traded?
Where can I find more information about OrganiGram?
What makes OrganiGram's cannabis products unique?
Has OrganiGram recently expanded its product lineup?
